|
Attendees: Paul "Pablo" Tompsett
None WOS High Sell To 1700
This month's area is Health and Pharmaceutical.
Bob recommended Internuvon stem cell research. Long term
punt. Gris has met them and likes them and their portfolio. Bob and Gris
are investng themselves for their daughter.
Bob recommended pharmaceutical co Smith and Nephew.
Boring but safe. Market down last 6 months but anticipated to improve late
2006. 7B 1H. Turnover œ4.8 billion. Divi 1.2%.
Dave recommended Dechra, pharmaceutical co supplying vet
and human ethical pharma industry in UK and overseas. New econmy range.
2005 turnover increased 16% to 1.2million. Divi 2%. EPS 19. 2B 1H.
Brett recommended Pilkington glass but that's not what we
asked for. He had to sit on the naughty step.
We voted on ReNeuron, Dechra, Smith and Nephew. ReNeuron
won, Dechra second.
We have £2000 to spend, we will put all into one share.
Mark to buy ReNeuron ASAP. Bob's
recommended high/low sell.
** Bob set to -50% and no upper limit at this stage
Johnny P's house in front of the big telly with our shoes
off, meeting before a football match. John to tell us what's a good day.
Any share.
Action by: All |